Patient-Reported Functional Impairment Due to Hearing Loss and Tinnitus After Cisplatin-Based Chemotherapy.

Victoria A Sanchez,Megan M Shuey,Paul C Dinh,Patrick O Monahan,Sophie D Fosså,Howard D Sesso,M Eileen Dolan,Lawrence H Einhorn,David J Vaughn,Neil E Martin,Darren R Feldman,Kurt Kroenke,Chunkit Fung,Robert D Frisina,Lois B Travis

Journal of clinical oncology : official journal of the American Society of Clinical Oncology（2023）

引用 9|浏览66

暂无评分

摘要

One in three TCS with HL report clinically significant functional impairment. Follow-up of cisplatin-treated survivors should include routine assessment for HL and tinnitus. Use of the HHIA and TPFQ permit risk stratification and referral to audiologists as needed, since HL adversely affects functional status and is the single largest modifiable risk factor for cognitive decline and dementia in the general population.

查看译文

关键词

tinnitus,chemotherapy,hearing,functional impairment,patient-reported,cisplatin-based

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要